Clinical Research Agreement Template for Singapore

A Clinical Research Agreement is a comprehensive legal document that governs the relationship between parties conducting clinical trials and research studies in Singapore. You'll need this agreement whenever research sponsors, institutions, principal investigators, or contract research organizations collaborate on medical research involving human subjects or clinical data.

When do you need this document?

You require a Clinical Research Agreement when initiating any clinical trial or research study in Singapore. This includes pharmaceutical companies sponsoring drug trials, medical device manufacturers testing new equipment, academic institutions conducting research studies, or when contract research organizations manage clinical trials on behalf of sponsors. The agreement becomes essential when multiple parties need to define their roles, responsibilities, and legal obligations under Singapore's regulatory framework. You'll also need this document when handling sensitive medical data, managing intellectual property rights, or ensuring compliance with Good Clinical Practice guidelines in Singapore.

Key legal considerations

Your Clinical Research Agreement must address several critical legal elements to ensure enforceability and compliance. Subject protection provisions are paramount, requiring detailed informed consent procedures and adherence to ethical guidelines established under the Human Biomedical Research Act 2015. Data handling clauses must comply with the Personal Data Protection Act 2012, particularly regarding collection, use, and disclosure of participant medical information. Intellectual property rights need clear definition, especially regarding ownership of research results, publications, and any discoveries made during the study. Indemnification provisions protect parties from liability arising from the research, while termination clauses outline procedures for ending the agreement early. Financial terms must specify payment schedules, budget allocation, and cost responsibilities among all parties involved.

Legal requirements in Singapore

Singapore imposes strict regulatory requirements that your Clinical Research Agreement must address. The Medicines Act governs all aspects of pharmaceutical research, requiring proper licensing and regulatory approvals before commencing trials. The Human Biomedical Research Act 2015 mandates institutional review board approval and establishes standards for protecting research subjects. Your agreement must demonstrate compliance with Singapore Guidelines for Good Clinical Practice, which adapt international ICH-GCP standards to local requirements. The Ministry of Health's Clinical Practice Guidelines provide additional framework requirements that must be incorporated. Research institutions must hold appropriate licenses, and principal investigators require proper qualifications and training certifications. The agreement should also address reporting obligations to regulatory authorities and procedures for handling adverse events or protocol deviations during the research period.